Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 27.36 % in the past year, substantial increase in net sales/revenue by 27.03 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -52.38 %, Marginal increase in other income during this quarter, up by 400%.
- Profit over the Year and quarter: Significant improvement in profitability for EIKO LIFESCIENCES LIMITED. Notable increase of 10.6 % in net profit Year to Year, EIKO LIFESCIENCES LIMITED’s profitability increased by 31.51 % in this quarter.
- EPS over the Year and quarter: EPS declined by -17.65 % Year to Year. EPS increased by 16.67 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 6.594 Cr | Rs. 6.611 Cr | Rs. 8.398 Cr | + 27.03 % | + 27.36 % |
| Expenses | Rs. 6.23 Cr | Rs. 6.14 Cr | Rs. 7.88 Cr | + 28.34 % | + 26.48 % |
| Operating Profit | Rs. 0.36 Cr | Rs. 0.47 Cr | Rs. 0.52 Cr | + 10.64 % | + 44.44 % |
| OPM % | 5.46 % | 7.11 % | 6.19 % | -0.92 % | + 0.73 % |
| Other Income | Rs. 0.21 Cr | Rs. 0.02 Cr | Rs. 0.1 Cr | + 400 % | -52.38 % |
| Interest | Rs. 0.04 Cr | Rs. 0.03 Cr | Rs. 0.02 Cr | -33.33 % | -50 % |
| Depreciation | Rs. 0.16 Cr | Rs. 0.16 Cr | Rs. 0.18 Cr | + 12.5 % | + 12.5 % |
| Profit before tax | Rs. 0.37 Cr | Rs. 0.3 Cr | Rs. 0.42 Cr | + 40 % | + 13.51 % |
| Tax % | 25.13 % | 18.56 % | 26 % | + 7.44 % | + 0.87 % |
| Net Profit | Rs. 0.28 Cr | Rs. 0.24 Cr | Rs. 0.31 Cr | + 29.17 % | + 10.71 % |
| EPS in Rs | Rs. 0.34 | Rs. 0.24 | Rs. 0.28 | + 16.67 % | -17.65 % |
Today, we’re looking at EIKO LIFESCIENCES LIMITED’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 27.36 %. However, it did see a marginal increase of 27.03 % from the previous quarter. Expenses ticked up slightly by 28.34 % quarter-on-quarter, aligning with the annual rise of 26.48 %. Operating profit, while up 44.44 % compared to last year, faced a quarter-on-quarter increase of 10.64 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.73 %, but a shrinkage of -0.92 % sequentially. Other income rose by 400 % compared to the last quarter, despite an annual decline of -52.38 %. Interest expenses dropped significantly by -33.33 % from the previous quarter, yet the year-over-year decrease remains at a moderate -50 %. Depreciation costs climbed by 12.5 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 12.5 %. Profit before tax grew annually by 13.51 % but saw an increase from the preceding quarter by 40 %.
Tax expenses as a percentage of profits increased slightly by 0.87 % compared to last year, with a more notable quarter-on-quarter increase of 7.44 %. Net profit rose by 10.71 % year-on-year but experienced a 29.17 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -17.65 % but a quarterly rise of 16.67 %. In summary, EIKO LIFESCIENCES LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 6.594 Cr | Rs. 6.611 Cr | Rs. 8.398 Cr | + 27.03 % | + 27.36 % |
| Expenses | Rs. 6.23 Cr | Rs. 6.14 Cr | Rs. 7.88 Cr | + 28.34 % | + 26.48 % |
| Operating Profit | Rs. 0.36 Cr | Rs. 0.47 Cr | Rs. 0.52 Cr | + 10.64 % | + 44.44 % |
| Net Profit | Rs. 0.28 Cr | Rs. 0.24 Cr | Rs. 0.31 Cr | + 29.17 % | + 10.71 % |
| EPS in Rs | Rs. 0.34 | Rs. 0.24 | Rs. 0.28 | + 16.67 % | -17.65 % |
In reviewing EIKO LIFESCIENCES LIMITED’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 27.36 % year-on-year growth, however, there was a minor increase of 27.03 % from the previous quarter. Expenses rose by 26.48 % compared to the previous year, with a 28.34 % increase quarter-on-quarter. Operating Profit surged by 44.44 % annually, and saw a 10.64 % increase from the last quarter.
Net Profit showed yearly increase of 10.71 %, and experienced a 29.17 % increase from the previous quarter. Earnings Per Share (EPS) fell by -17.65 % annually, however rose by 16.67 % compared to the last quarter. In essence, while EIKO LIFESCIENCES LIMITED exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
